Xanthohumol ameliorates atherosclerotic plaque formation, hypercholesterolemia, and hepatic steatosis in ApoE-deficient mice

Molecular Nutrition and Food Research

Volumn 57, Issue 10, 2013, Pages 1718-1728

  Doddapattar, Prakash ^a   Radović, Branislav ^a   Patankar, Jay V ^a   Obrowsky, Sascha ^a   Jandl, Katharina ^a   Nusshold, Christoph ^a   Kolb, Dagmar ^a   Vujić, Nemanja ^a   Doshi, Lalit ^a   Chandak, Prakash G ^a   Goeritzer, Madeleine ^a   Ahammer, Helmut ^a   Hoefler, Gerald ^a   Sattler, Wolfgang ^a   Kratky, Dagmar ^a  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

Author keywords

AMPK signaling; Atherosclerosis; Inflammation; Lipid metabolism; Xanthohumol

Indexed keywords

HUMULUS; MUS;

ACETYL COENZYME A CARBOXYLASE; APOLIPOPROTEIN E; CARNITINE PALMITOYLTRANSFERASE; CCL2 PROTEIN, MOUSE; CHOLESTEROL; FLAVONOID; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; PROPIOPHENONE DERIVATIVE; SREBF1 PROTEIN, MOUSE; SREBF2 PROTEIN, MOUSE; STEROL REGULATORY ELEMENT BINDING PROTEIN 1; STEROL REGULATORY ELEMENT BINDING PROTEIN 2; TRIACYLGLYCEROL; XANTHOHUMOL;

AMPK SIGNALING; ANIMAL; ARTICLE; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; BLOOD; DRUG ANTAGONISM; DRUG EFFECT; FATTY LIVER; FEMALE; GENETICS; HYPERCHOLESTEROLEMIA; INFLAMMATION; LIPID METABOLISM; LIPOGENESIS; LIVER; METABOLISM; MOUSE; PHOSPHORYLATION;

AMPK SIGNALING; ATHEROSCLEROSIS; INFLAMMATION; LIPID METABOLISM; XANTHOHUMOL;

ACETYL-COA CARBOXYLASE; AMP-ACTIVATED PROTEIN KINASES; ANIMALS; APOLIPOPROTEINS E; CARNITINE O-PALMITOYLTRANSFERASE; CHEMOKINE CCL2; CHOLESTEROL; FATTY LIVER; FEMALE; FLAVONOIDS; HYPERCHOLESTEROLEMIA; LIPID METABOLISM; LIPOGENESIS; LIVER; MICE; PHOSPHORYLATION; PLAQUE, ATHEROSCLEROTIC; PROPIOPHENONES; RNA, MESSENGER; STEROL REGULATORY ELEMENT BINDING PROTEIN 1; STEROL REGULATORY ELEMENT BINDING PROTEIN 2; TRIGLYCERIDES;

EID: 84884958987     PISSN: 16134125     EISSN: 16134133     Source Type: Journal    
DOI: 10.1002/mnfr.201200794     Document Type: Article

References (50)

1. Brown, M. S., Goldstein, J. L., How LDL receptors influence cholesterol and atherosclerosis. Sci. Am. 1984, 251, 58-66.
2. Hansson, G. K., Hermansson, A., The immune system in atherosclerosis. Nat. Immunol. 2011, 12, 204-212.
3. Ross, R., Atherosclerosis-an inflammatory disease. N. Engl. J. Med. 1999, 340, 115-126.
4. Bakkeren, H. F., Kuipers, F., Vonk, R. J., Van Berkel, T. J., Evidence for reverse cholesterol transport in vivo from liver endothelial cells to parenchymal cells and bile by high-density lipoprotein. Biochem. J. 1990, 268, 685-691.
5. Nestel, P. J., Whyte, H. M., Goodman, D. S., Distribution and turnover of cholesterol in humans. J. Clin. Invest. 1969, 48, 982-991.
6. Percy-Robb, I. W., Boyd, G. S., The synthesis of bile acids in perfused rat liver subjected to chronic biliary drainage. Biochem. J. 1970, 118, 519-530.
7. Casaschi, A., Maiyoh, G. K., Rubio, B. K., Li, R. W. et al., The chalcone xanthohumol inhibits triglyceride and apolipoprotein B secretion in HepG2 cells. J. Nutr. 2004, 134, 1340-1346.
8. Nozawa, H., Xanthohumol, the chalcone from beer hops (Humulus lupulus L.), is the ligand for farnesoid X receptor and ameliorates lipid and glucose metabolism in KK-A(y) mice. Biochem. Biophys. Res. Commun. 2005, 336, 754-761.
9. Yang, J. Y., Della-Fera, M. A., Rayalam, S., Baile, C. A., Effect of xanthohumol and isoxanthohumol on 3T3-L1 cell apoptosis and adipogenesis. Apoptosis 2007, 12, 1953-1963.
10. Legette, L. L., Moreno Luna, A. Y., Reed, R. L., Miranda, C. L. et al., Xanthohumol lowers body weight and fasting plasma glucose in obese male Zucker fa/fa rats. Phytochemistry 2012, DOI: 10.1016/j.phytochem.2012.04.018.
11. Cho, Y. C., Kim, H. J., Kim, Y. J., Lee, K. Y. et al., Differential anti-inflammatory pathway by xanthohumol in IFN-gamma and LPS-activated macrophages. Int. Immunopharmacol. 2008, 8, 567-573.
12. Cho, Y. C., You, S. K., Kim, H. J., Cho, C. W. et al., Xanthohumol inhibits IL-12 production and reduces chronic allergic contact dermatitis. Int. Immunopharmacol. 2010, 10, 556-561.
13. Lupinacci, E., Meijerink, J., Vincken, J. P., Gabriele, B. et al., Xanthohumol from hop (Humulus lupulus L.) is an efficient inhibitor of monocyte chemoattractant protein-1 and tumor necrosis factor-alpha release in LPS-stimulated RAW 264.7 mouse macrophages and U937 human monocytes. J. Agric. Food Chem. 2009, 57, 7274-7281.
14. Plump, A. S., Smith, J. D., Hayek, T., Aalto-Setala, K. et al., Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells. Cell 1992, 71, 343-353.
15. Chandak, P. G., Obrowsky, S., Radovic, B., Doddapattar, P. et al., Lack of acyl-CoA:diacylglycerol acyltransferase 1 reduces intestinal cholesterol absorption and attenuates atherosclerosis in apolipoprotein E knockout mice. Biochim. Biophys. Acta 2011, 1811, 1011-1020.
16. Wakil, S. J., Stoops, J. K., Joshi, V. C., Fatty acid synthesis and its regulation. Annu. Rev. Biochem. 1983, 52, 537-579.
17. Munday, M. R., Campbell, D. G., Carling, D., Hardie, D. G., Identification by amino acid sequencing of three major regulatory phosphorylation sites on rat acetyl-CoA carboxylase. Eur. J. Biochem. 1988, 175, 331-338.
18. Witters, L. A., Nordlund, A. C., Marshall, L., Regulation of intracellular acetyl-CoA carboxylase by ATP depletors mimics the action of the 5'-AMP-activated protein kinase. Biochem. Biophys. Res. Commun. 1991, 181, 1486-1492.
19. Muoio, D. M., Seefeld, K., Witters, L. A., Coleman, R. A., AMP-activated kinase reciprocally regulates triacylglycerol synthesis and fatty acid oxidation in liver and muscle: evidence that sn-glycerol-3-phosphate acyltransferase is a novel target. Biochem. J. 1999, 338 (Pt 3), 783-791.
20. Winder, W. W., Hardie, D. G., AMP-activated protein kinase, a metabolic master switch: possible roles in type 2 diabetes. Am. J. Physiol. 1999, 277, E1-E10.
21. Legette, L., Ma, L., Reed, R. L., Miranda, C. L. et al., Pharmacokinetics of xanthohumol and metabolites in rats after oral and intravenous administration. Mol. Nutr. Food Res. 2012, 56, 466-474.
22. Hanske, L., Loh, G., Sczesny, S., Blaut, M. et al., Recovery and metabolism of xanthohumol in germ-free and human microbiota-associated rats. Mol. Nutr. Food Res. 2010, 54, 1405-1413.
23. Boring, L., Gosling, J., Cleary, M., Charo, I. F., Decreased lesion formation in CCR2-/- mice reveals a role for chemokines in the initiation of atherosclerosis. Nature 1998, 394, 894-897.
24. Gosling, J., Slaymaker, S., Gu, L., Tseng, S. et al., MCP-1 deficiency reduces susceptibility to atherosclerosis in mice that overexpress human apolipoprotein B. J. Clin. Invest. 1999, 103, 773-778.
25. Hirata, H., Yimin, Segawa, S., Ozaki, M. et al., Xanthohumol prevents atherosclerosis by reducing arterial cholesterol content via CETP and apolipoprotein E in CETP-transgenic mice. PLoS One 2012, 7, 8.
26. Dorn, C., Massinger, S., Wuzik, A., Heilmann, J. et al., Xanthohumol suppresses inflammatory response to warm ischemia-reperfusion induced liver injury. Exp. Mol. Pathol. 2012, 94, 10-16.
27. Monteiro, R., Calhau, C., Silva, A. O., Pinheiro-Silva, S. et al., Xanthohumol inhibits inflammatory factor production and angiogenesis in breast cancer xenografts. J. Cell. Biochem. 2008, 104, 1699-1707.
28. Gao, X., Deeb, D., Liu, Y., Gautam, S. et al., Immunomodulatory activity of xanthohumol: inhibition of T cell proliferation, cell-mediated cytotoxicity and Th1 cytokine production through suppression of NF-kappaB. Immunopharmacol. Immunotoxicol. 2009, 31, 477-484.
29. Decleves, A. E., Mathew, A. V., Cunard, R., Sharma, K., AMPK mediates the initiation of kidney disease induced by a high-fat diet. J. Am. Soc. Nephrol. 2011, 22, 1846-1855.
30. Miyokawa-Gorin, K., Takahashi, K., Handa, K., Kitahara, A. et al., Induction of mitochondrial uncoupling enhances VEGF(1)(2)(0) but reduces MCP-1 release in mature 3T3-L1 adipocytes: possible regulatory mechanism through endogenous ER stress and AMPK-related pathways. Biochem. Biophys. Res. Commun. 2012, 419, 200-205.
31. Jeong, H. W., Hsu, K. C., Lee, J. W., Ham, M. et al., Berberine suppresses proinflammatory responses through AMPK activation in macrophages. Am. J. Physiol. Endocrinol. Metab. 2009, 296, E955-E964.
32. Ewart, M. A., Kohlhaas, C. F., Salt, I. P., Inhibition of tumor necrosis factor alpha-stimulated monocyte adhesion to human aortic endothelial cells by AMP-activated protein kinase. Arterioscler. Thromb. Vasc. Biol. 2008, 28, 2255-2257.
33. Li, Y., Xu, S., Mihaylova, M. M., Zheng, B. et al., AMPK phosphorylates and inhibits SREBP activity to attenuate hepatic steatosis and atherosclerosis in diet-induced insulin-resistant mice. Cell Metab. 2011, 13, 376-388.
34. Mao, J., DeMayo, F. J., Li, H., Abu-Elheiga, L. et al., Liver-specific deletion of acetyl-CoA carboxylase 1 reduces hepatic triglyceride accumulation without affecting glucose homeostasis. Proc. Natl. Acad. Sci. USA 2006, 103, 8552-8557.
35. Browning, J. D., Horton, J. D., Molecular mediators of hepatic steatosis and liver injury. J. Clin. Invest. 2004, 114, 147-152.
36. Avula, B., Ganzera, M., Warnick, J. E., Feltenstein, M. W. et al., High-performance liquid chromatographic determination of xanthohumol in rat plasma, urine, and fecal samples. J. Chromatogr. Sci. 2004, 42, 378-382.
37. Vanhoecke, B. W., Delporte, F., Van Braeckel, E., Heyerick, A. et al., A safety study of oral tangeretin and xanthohumol administration to laboratory mice. In Vivo 2005, 19, 103-107.
38. Hussong, R., Frank, N., Knauft, J., Ittrich, C. et al., A safety study of oral xanthohumol administration and its influence on fertility in Sprague Dawley rats. Mol. Nutr. Food Res. 2005, 49, 861-867.
39. Dorn, C., Bataille, F., Gaebele, E., Heilmann, J. et al., Xanthohumol feeding does not impair organ function and homoeostasis in mice. Food Chem. Toxicol. 2010, 48, 1890-1897.
40. Sato, R., Goldstein, J. L., Brown, M. S., Replacement of serine-871 of hamster 3-hydroxy-3-methylglutaryl-CoA reductase prevents phosphorylation by AMP-activated kinase and blocks inhibition of sterol synthesis induced by ATP depletion. Proc. Natl. Acad. Sci USA 1993, 90, 9261-9265.
41. Clarke, P. R., Hardie, D. G., Regulation of HMG-CoA reductase: identification of the site phosphorylated by the AMP-activated protein kinase in vitro and in intact rat liver. EMBO J 1990, 9, 2439-2446.
42. Namkoong, C., Kim, M. S., Jang, P. G., Han, S. M. et al., Enhanced hypothalamic AMP-activated protein kinase activity contributes to hyperphagia in diabetic rats. Diabetes 2005, 54, 63-68.
43. Albini, A., Dell'Eva, R., Vene, R., Ferrari, N. et al., Mechanisms of the antiangiogenic activity by the hop flavonoid xanthohumol: NF-kappaB and Akt as targets. FASEB J 2006, 20, 527-529.
44. Dell'Eva, R., Ambrosini, C., Vannini, N., Piaggio, G. et al., AKT/NF-kappaB inhibitor xanthohumol targets cell growth and angiogenesis in hematologic malignancies. Cancer 2007, 110, 2007-2011.
45. Yang, J. Y., Della-Fera, M. A., Rayalam, S., Baile, C. A., Enhanced effects of xanthohumol plus honokiol on apoptosis in 3T3-L1 adipocytes. Obesity (Silver Spring) 2008, 16, 1232-1238.
46. Deeb, D., Gao, X., Jiang, H., Arbab, A. S. et al., Growth inhibitory and apoptosis-inducing effects of xanthohumol, a prenylated chalone present in hops, in human prostate cancer cells. Anticancer Res. 2010, 30, 3333-3339.
47. Hahn-Windgassen, A., Nogueira, V., Chen, C. C., Skeen, J. E. et al., Akt activates the mammalian target of rapamycin by regulating cellular ATP level and AMPK activity. J. Biol. Chem. 2005, 280, 32081-32089.
48. Hoekstra, M., Kruijt, J. K., Van Eck, M., Van Berkel, T. J., Specific gene expression of ATP-binding cassette transporters and nuclear hormone receptors in rat liver parenchymal, endothelial, and Kupffer cells. J. Biol. Chem. 2003, 278, 25448-25453.
49. Kennedy, M. A., Barrera, G. C., Nakamura, K., Baldan, A. et al., ABCG1 has a critical role in mediating cholesterol efflux to HDL and preventing cellular lipid accumulation. Cell Metab. 2005, 1, 121-131.
50. Ji, A., Wroblewski, J. M., Cai, L., de Beer, M. C. et al., Nascent HDL formation in hepatocytes and role of ABCA1, ABCG1, and SR-BI. J. Lipid Res. 2012, 53, 446-455.